Australia TGA Medical Device Regulations

Our regulatory consulting specialists support regulatory compliance with the Australia TGA Medical Device Regulations

Therapeutic Goods Act 1989

Australia TGA Medical Device Regulations

In Australia, the Therapeutic Goods Administration (TGA), part of the Department of Health and Aged Care, ensures the safety, quality, and efficacy of medicines, medical devices, and biologicals. These are regulated under the Therapeutic Goods Act 1989, a key legislative framework that defines and governs therapeutic goods in the country.

Before entering the Australian market, manufacturers must determine whether their product falls under the scope of the Therapeutic Goods Act 1989. If it does, the next step is to build comprehensive technical documentation. This documentation demonstrates that the device meets Australian standards, paving the way for TGA approval, which is essential for legally supplying medical devices.

Australia’s Medical Device Single Audit Program (MDSAP) participation further streamlines the regulatory process. Manufacturers must ensure their Quality Management System (QMS) complies with Australian requirements. This can be achieved by obtaining MDSAP certification with Australia in scope or through a QMS certification tailored to local regulations.

By aligning with these regulatory requirements, manufacturers ensure compliance and gain access to one of the most rigorous and respected healthcare markets globally.

https://www.qservegroup.com/write/Afbeeldingen1/05. Market Access/Australia TGV Medical Device Regulations.jpg?preset=content

GO-TO-MARKET STRATEGY AND REGISTRATION SUPPORT

Do you need assistance with your strategy for the Australia TGA Medical Device Regulations? 

 

Contact us

 

Medical Device Classification in Australia

Risk-based classification

All medical devices are classified using a risk-based approach comparable to the European Union and FDA classification systems. The range spans Class I (sterile/measuring), IIa, IIb, and III, where Class I (including sterile/medium) is low risk and Class III and AIMDs are high risk.

There are a few exemptions:

  • All disinfectors are classified as Class IIb in Australia. 
  • Depending on the duration of the contact, devices that are in contact with the central nervous system (CNS) are classified differently from the EU, where all these devices are classified as Class III devices.
  • Note that a microbiome and recombined origin device, Class III in Australia, must undergo a full conformity assessment. This entails a full technical file review, including the design and the TGA's audits of the facility.
  • Note that software has a different risk classification, highly dependent on its intended use.
Although the classification system may be comparable to other overseas systems, manufacturers must determine their device's risk class based on the classification rules set by the Australia TGA Medical Device Regulations. Given the differences in interpretation, conducting a classification assessment according to the Australian regulations at an early stage is beneficial.

Medical Device Approval Australia

Australia TGA Medical Device Regulations

The TGA approval process involves several key steps to ensure compliance with Australian regulations.

  1. Determine the Risk Classification
    Start by identifying your device's or IVD's risk classification. Due to specific risk classification rules in Australia, your risk classification may differ from that in other countries.
  2. Appoint an Australian Sponsor
    Foreign manufacturers must appoint a local Australian Sponsor. The Sponsor is the manufacturer and TGA liaison, ensuring smooth communication and regulatory compliance.
  3. Select a Regulatory Pathway
    Choose the appropriate regulatory pathway for your device:
    • Entire Conformity Assessment Route: A comprehensive review of your device's compliance.
    • Abridged Route: A streamlined process for devices with approvals in recognized markets.
  4. Prepare Technical Documentation
    Compile a technical file that includes Australia-specific documents. Update your quality management system (QMS) to meet Australian requirements.
  5. Submit the Application
    Submit your application to the TGA and enter the review phase. Depending on your device's risk classification, the TGA may request additional information or clarification.
  6. Receive TGA Approval
    Once approved, the TGA will issue your device's ARTG listing number and certificate.
 
Latest regulatory developments

The TGA clarified its approach to the lapsing of conformity assessment documents due to audit delays (e.g., as a result of COVID-19, EU MDR transition, and limited EU notified body designations).

The TGA no longer accepts ISO 13485 certificates to support applications for new IVD devices, except if the manufacturer made a declaration of conformity under the EU IVDD before 26 May 2022. Approved IVDs supported by ISO 13485 certificates remain valid until the certificate expires.

Proposed application audit

Manufacturers can respond to the open consultation on the proposed application audit framework for medical devices, including feedback on the following: 

  • risk factors informing non-mandatory audit selection
  • criteria for mandatory audits
  • the evidence to be provided with applications to inform audit selection
  • limiting the number of substantial assessment rounds
  • mechanisms to improve the visibility of application audit timeframes
  • cost recovery measures for non-mandatory audits. 

Contact us

Qserve services for Australia

  • Global Regulatory Strategy
  • Registration support in Australia
  • TGA certification
  • Australia sponsor support
  • Translation label and IFUs based on requirements
  • Conformity Assessment route support
  • Abridged route support for CE, FDA, and MDSAP compliance

Qserve knows the essential requirements to ensure how to achieve regulatory compliance.  

Services

Representation for foreign manufacturers

Australian Sponsor requirement

A foreign manufacturer must appoint a sponsor if they want to supply devices in Australia. The sponsor must be a resident of Australia or be an incorporated body conducting business in Australia. This could be your distributor, but appointing an independent third party gets more control of registration and provides more flexibility in changing distributors or appointing multiple distributors for better market penetration.

Your sponsor should:
  • Apply to the TGA to have therapeutic goods included in the ARTG
  • Notify the TGA of any incidents and performance issues
  • Assist the TGA and the manufacturer with investigations
  • Maintain distribution records for products supplied to Australia
  • Include their name and address on the labels and IFU

Contact us


 

Additional Regulatory Requirements

Required Registration Documentation

The required documentation depends on the registration route and risk class. Overall, you need to consider the following documents:

  • Labels, instructions for use (IFU), packaging
  • Patient information leaflet
  • Cards for implantable medical devices, if applicable
  • Device classification assessment
  • Risk management reports 
  • Clinical evidence plan and reports
  • Validation and Verification Test Reports
  • QMS certification (e.g., MDSAP certificate or TGA Certificate) 
  • Australian Declaration of Conformity (different templates for every risk class)
  • Australian Essential Principles Checklist
  • Australia-specific post-market surveillance requirements
 

Regulatory Routes for Australia

Australia offers two primary regulatory pathways for medical device and IVD approval under the TGA Medical Device Regulations: the Abridged Route and the TGA Conformity Assessment Route. Each path is designed to accommodate different prior approvals and device readiness levels.

Abridged Route
The Abridged Route is a faster assessment process for devices already recognized overseas regulatory approvals. This pathway reduces review timelines, making it an efficient option for manufacturers with prior certifications.

Eligible approvals for the abridged route include:

  • CE Mark
  • FDA Approval
  • Certification under the Medical Device Single Audit Program (MDSAP)
  • Approvals from Singapore, Malaysia, or India

Manufacturers can streamline their journey to TGA approval and market access by leveraging these existing certifications.


TGA Conformity Assessment Route
If the abridged route is not an option, manufacturers must follow the TGA Conformity Assessment Route. This involves a comprehensive and systematic review by the Therapeutic Goods Administration (TGA). Key elements of the conformity assessment include:

  • Examination of technical documentation to ensure compliance with the TGA’s essential principles.
  • Review of the manufacturer’s quality management system (QMS).
  • Verification that the medical device or IVD meets all regulatory requirements for safety and performance ensures that the product adheres to Australia’s rigorous standards, paving the way for market approval.

Why Consider Australia for Medical Device Market Entry?
Australia’s participation in global regulatory frameworks, such as MDSAP, and its recognition of approvals from other jurisdictions make it an attractive market for manufacturers. With existing certifications, entry can be faster and more efficient, allowing you to capitalize on opportunities in this growing healthcare market.


Registration Validity

Medical Device Approval Australia


For submissions with Class Is, Im IIa, and IIb that rely on MDSAP, CE, or US FDA, the registration will remain valid if the supporting certifications are still active and within the expiry date of the respective certification.

For the TGA conformity assessment certificate, a validity of five years applies.

Regulatory timelines and fees

How long does it take to enter
the Australian medical device market? 

The review times depend on the risk class and the completeness of the documentation that is provided to the TGA, and if your device is subject to auditing but the overall timelines are as follows:

  • Class I: 24 hours to 4 weeks
  • Class Is, Im, IIa, and IIb: 2-4 months
  • Class III and AIMD: 6-8 months
  • Full TGA Conformity Assessment: 18-24 months